Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Joachim Doua"'
Autor:
Neil Goldstein, Chelsea McLean, Auguste Gaddah, Joachim Doua, Babajide Keshinro, Linda Bus-Jacobs, Jenny Hendriks, Kerstin Luhn, Cynthia Robinson, Macaya Douoguih
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTThis phase-3, double-blind, placebo-controlled study (NCT04228783) evaluated lot-to-lot consistency of the Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen. Participants were randomized (6:6:6:1) to receive the two-dose regimen from three consec
Externí odkaz:
https://doaj.org/article/65e3268d9a954502879e597a8bb39643
Autor:
Yorokpa Joachim Doua, Hanneke Dominicus, Julius Mugwagwa, Suzelle Magalie Gombe, Jude Nwokike
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-6 (2019)
Abstract Background This research reviewed major Clinical Trial Registries (CTRs) and assessed the availability of fields on quality assurance for approved medicines used as Investigational Medicinal Products (IMPs) in phase IV clinical trials. Metho
Externí odkaz:
https://doaj.org/article/079c53282d9e4e63b0694b223c22441a
Autor:
Stephen P. Fortin, Luis Hernandez Pastor, Joachim Doua, Michal Sarnecki, Joel Swerdel, Jamie Colasurdo, Jeroen Geurtsen
Publikováno v:
Pharmacoepidemiology and Drug Safety. 31:983-991
Evaluation of novel code-based algorithms to identify invasive Escherichia coli disease (IED) among patients in healthcare databases.Inpatient visits with microbiological evidence of invasive bacterial disease were extracted from the Optum© electron
Autor:
Joachim Doua, Jeroen Geurtsen, Jesus Rodriguez-Baño, Oliver A Cornely, Oscar Go, Aina Gomila-Grange, Andrew Kirby, Peter Hermans, Andrea Gori, Valentina Zuccaro, Stefan Gravenstein, Marc Bonten, Jan Poolman, Michal Sarnecki
Background Invasive Escherichia coli disease (IED), including bloodstream infection, sepsis, and septic shock, can lead to high hospitalization and mortality rates. This multinational study describes the clinical profile of patients with IED in terti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fa71ac25d26e9309ef7329d8c56d099
http://hdl.handle.net/2445/198343
http://hdl.handle.net/2445/198343
Autor:
Joachim Doua, Jesús Rodriguez Baño, Jeroen Geurtsen, Oscar Go, Michal Sarnecki, Tuba Vilken, Bart Spiessens, Christine Vallejo, Herman Goossens, Marc Bonten, Jan Poolman, Miquel Ekkelenkamp
Publikováno v:
Open Forum Infectious Diseases. 9
Background Invasive extraintestinal pathogenic Escherichia coli disease (IED) occurs more frequently with increasing age, and antimicrobial resistance (AMR) can complicate treatment. Yet IED is under-monitored by major disease surveillance systems. I
Autor:
Joachim Doua, Miquel Ekkelenkamp, Stephen Ruhmel, Kimberly Leathers, Clinical Research Associate, Oscar Go, Ranee Chatterjee, Michal Sarnecki, Jan Poolman, Marc Bonten
Publikováno v:
Open Forum Infectious Diseases. 9
Background A vaccine developed to prevent invasive extraintestinal pathogenic Escherichia coli disease (IED) is being evaluated in a phase 3 clinical trial (NCT04899336). However, historical performance of similar clinical trials has been challenged
Autor:
Joachim Doua, Carlos Fierro, Michal Sarnecki, Bart Spiessens, Oscar Go, Todd Davies, Germie van den Dobbelsteen, Jan Poolman, Wouter Haazen
Publikováno v:
Open Forum Infectious Diseases. 9
Background This Phase 1/2a study (NCT03819049) assessed the safety, reactogenicity, and immunogenicity of 3 doses of VAC52416 (ExPEC10V), a vaccine candidate to prevent invasive extraintestinal pathogenic Escherichia coli (ExPEC) disease. Methods Dat
Autor:
Stephen P. Fortin, Joel Swerdel, Michal Sarnecki, Joachim Doua, Jamie Colasurdo, Jeroen Geurtsen
Publikováno v:
Pharmacoepidemiology and drug safetyREFERENCES. 31(9)
In real-world evidence research, reliability of coding in healthcare databases dictates the accuracy of code-based algorithms in identifying conditions such as urinary tract infection (UTI). This study evaluates the performance characteristics of cod
Autor:
Jude Nwokike, Julius Mugwagwa, Yorokpa Joachim Doua, Hanneke Dominicus, Suzelle Magalie Gombe
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-6 (2019)
Trials
Trials
Background This research reviewed major Clinical Trial Registries (CTRs) and assessed the availability of fields on quality assurance for approved medicines used as Investigational Medicinal Products (IMPs) in phase IV clinical trials. Methods Two re
Autor:
Hanneke Dominicus, Joachim Doua
Publikováno v:
BMJ Global Health. 4:A8.2-A8
BackgroundThe proven worrisome quality of medicines marketed in developing countries also affects clinical trials (CTs) as they may be used as Investigational Medicinal Products (IMPs). By regulation, CT sponsors should assure IMP’s quality and des